Accession Number:

ADA455577

Title:

Targeting Stat3 With G-Quartet Oligonucleotides in Metastic Prostate Cancer

Descriptive Note:

Final rept. 1 Apr 2003-31 Mar 2006

Corporate Author:

BAYLOR COLL OF MEDICINE HOUSTON TX

Personal Author(s):

• Jing, Naijie

Report Date:

2006-04-01

Pagination or Media Count:

46.0

Abstract:

During the three year funding period, we have well developed a novel and potent Stat3 inhibitor, which represents a promising class of anti-cancer drug in treatment of human cancers, including prostate, breast, head and neck, and long cancers. We appreciate to get a DOD funding for supporting this project. However, the funding period is too short to fulfill the preclinical drug development.

Descriptors:

• *PROSTATE CANCER
• POTENCY
• PROSTATE GLAND
• CHEMOTHERAPEUTIC AGENTS
• METASTASIS

Subject Categories:

• Anatomy and Physiology
• Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE